Published in J Immunol on March 04, 2013
T cell responses to cytomegalovirus. Nat Rev Immunol (2016) 0.95
Competition for antigen at the level of the APC is a major determinant of immunodominance during memory inflation in murine cytomegalovirus infection. J Immunol (2013) 0.85
Murine CMV Infection Induces the Continuous Production of Mucosal Resident T Cells. Cell Rep (2015) 0.82
The viral context instructs the redundancy of costimulatory pathways in driving CD8(+) T cell expansion. Elife (2015) 0.81
A novel murine cytomegalovirus vaccine vector protects against Mycobacterium tuberculosis. J Immunol (2014) 0.80
The Neonatal CD8+ T Cell Repertoire Rapidly Diversifies during Persistent Viral Infection. J Immunol (2016) 0.79
miR-150 Regulates Differentiation and Cytolytic Effector Function in CD8+ T cells. Sci Rep (2015) 0.78
Type I Interferon Released by Myeloid Dendritic Cells Reversibly Impairs Cytomegalovirus Replication by Inhibiting Immediate Early Gene Expression. J Virol (2015) 0.78
Peptide Processing Is Critical for T-Cell Memory Inflation and May Be Optimized to Improve Immune Protection by CMV-Based Vaccine Vectors. PLoS Pathog (2016) 0.78
Cytomegalovirus and immunotherapy: opportunistic pathogen, novel target for cancer and a promising vaccine vector. Immunotherapy (2016) 0.76
Intratumoral Infection with Murine Cytomegalovirus Synergizes with PD-L1 Blockade to Clear Melanoma Lesions and Induce Long-term Immunity. Mol Ther (2016) 0.76
Mouse newborn cells allow highly productive mouse cytomegalovirus replication, constituting a novel convenient primary cell culture system. PLoS One (2017) 0.75
Cloning, Assembly, and Modification of the Primary Human Cytomegalovirus Isolate Toledo by Yeast-Based Transformation-Associated Recombination. mSphere (2017) 0.75
Intratumoral infection by CMV may change the tumor environment by directly interacting with tumor-associated macrophages to promote cancer immunity. Hum Vaccin Immunother (2017) 0.75
Profound early control of highly pathogenic SIV by an effector memory T-cell vaccine. Nature (2011) 9.30
Effector memory T cell responses are associated with protection of rhesus monkeys from mucosal simian immunodeficiency virus challenge. Nat Med (2009) 7.33
Coding potential of laboratory and clinical strains of human cytomegalovirus. Proc Natl Acad Sci U S A (2003) 4.37
Evasion of CD8+ T cells is critical for superinfection by cytomegalovirus. Science (2010) 3.31
High-resolution gene expression profiling for simultaneous kinetic parameter analysis of RNA synthesis and decay. RNA (2008) 3.13
Characterization of the human cytomegalovirus gH/gL/UL128-131 complex that mediates entry into epithelial and endothelial cells. J Virol (2007) 2.53
Human cytomegalovirus entry into epithelial and endothelial cells depends on genes UL128 to UL150 and occurs by endocytosis and low-pH fusion. J Virol (2006) 2.45
Conserved principles of mammalian transcriptional regulation revealed by RNA half-life. Nucleic Acids Res (2009) 2.26
Role of murine cytomegalovirus US22 gene family members in replication in macrophages. J Virol (2003) 2.09
Natural killer cells promote early CD8 T cell responses against cytomegalovirus. PLoS Pathog (2007) 1.93
The major virus-producing cell type during murine cytomegalovirus infection, the hepatocyte, is not the source of virus dissemination in the host. Cell Host Microbe (2008) 1.92
Systematic analysis of viral and cellular microRNA targets in cells latently infected with human gamma-herpesviruses by RISC immunoprecipitation assay. Cell Host Microbe (2010) 1.91
Mouse cytomegalovirus microRNAs dominate the cellular small RNA profile during lytic infection and show features of posttranscriptional regulation. J Virol (2007) 1.90
Herpesvirus genetics has come of age. Trends Microbiol (2002) 1.66
A human cytomegalovirus gO-null mutant fails to incorporate gH/gL into the virion envelope and is unable to enter fibroblasts and epithelial and endothelial cells. J Virol (2009) 1.63
Comprehensive mutational analysis of a herpesvirus gene in the viral genome context reveals a region essential for virus replication. J Virol (2004) 1.59
Key role of splenic myeloid DCs in the IFN-alphabeta response to adenoviruses in vivo. PLoS Pathog (2008) 1.58
Novel polyomaviruses of nonhuman primates: genetic and serological predictors for the existence of multiple unknown polyomaviruses within the human population. PLoS Pathog (2013) 1.53
Shedding light on the elusive role of endothelial cells in cytomegalovirus dissemination. PLoS Pathog (2011) 1.51
Functional domains of murine cytomegalovirus nuclear egress protein M53/p38. J Virol (2006) 1.41
Degradation of cellular mir-27 by a novel, highly abundant viral transcript is important for efficient virus replication in vivo. PLoS Pathog (2012) 1.40
Common and specific properties of herpesvirus UL34/UL31 protein family members revealed by protein complementation assay. J Virol (2006) 1.34
A capsid-encoded PPxY-motif facilitates adenovirus entry. PLoS Pathog (2010) 1.29
A cyclooxygenase-2 homologue encoded by rhesus cytomegalovirus is a determinant for endothelial cell tropism. J Virol (2004) 1.28
The herpesviral Fc receptor fcr-1 down-regulates the NKG2D ligands MULT-1 and H60. J Exp Med (2006) 1.27
Endogenous human cytomegalovirus gB is presented efficiently by MHC class II molecules to CD4+ CTL. J Exp Med (2005) 1.26
Ultrashort and progressive 4sU-tagging reveals key characteristics of RNA processing at nucleotide resolution. Genome Res (2012) 1.24
A replicating cytomegalovirus-based vaccine encoding a single Ebola virus nucleoprotein CTL epitope confers protection against Ebola virus. PLoS Negl Trop Dis (2011) 1.23
Selective down-regulation of the NKG2D ligand H60 by mouse cytomegalovirus m155 glycoprotein. J Virol (2005) 1.21
Dominant-negative FADD rescues the in vivo fitness of a cytomegalovirus lacking an antiapoptotic viral gene. J Virol (2007) 1.07
Genetic reconstitution of the human adenovirus type 2 temperature-sensitive 1 mutant defective in endosomal escape. Virol J (2009) 1.07
Transcriptional activation of the adenoviral genome is mediated by capsid protein VI. PLoS Pathog (2012) 1.06
The nucleotide sequence and a first generation gene transfer vector of species B human adenovirus serotype 3. Virology (2005) 1.05
Conditional cytomegalovirus replication in vitro and in vivo. J Virol (2005) 1.03
Cytomegalovirus microRNAs facilitate persistent virus infection in salivary glands. PLoS Pathog (2010) 1.03
Dominant negative mutants of the murine cytomegalovirus M53 gene block nuclear egress and inhibit capsid maturation. J Virol (2010) 1.01
Two distinct transport motifs in the adenovirus E3/10.4-14.5 proteins act in concert to down-modulate apoptosis receptors and the epidermal growth factor receptor. J Biol Chem (2003) 1.00
Random screening for dominant-negative mutants of the cytomegalovirus nuclear egress protein M50. J Virol (2007) 0.98
Targeted deletion of regions rich in immune-evasive genes from the cytomegalovirus genome as a novel vaccine strategy. J Virol (2007) 0.98
Real-time transcriptional profiling of cellular and viral gene expression during lytic cytomegalovirus infection. PLoS Pathog (2012) 0.98
Stepwise loss of fluorescent core protein V from human adenovirus during entry into cells. J Virol (2010) 0.97
The m74 gene product of murine cytomegalovirus (MCMV) is a functional homolog of human CMV gO and determines the entry pathway of MCMV. J Virol (2010) 0.97
A spread-deficient cytomegalovirus for assessment of first-target cells in vaccination. J Virol (2010) 0.96
Differential susceptibility of RAE-1 isoforms to mouse cytomegalovirus. J Virol (2009) 0.95
Adenovirus vectors based on human adenovirus type 19a have high potential for human muscle-directed gene therapy. Hum Gene Ther (2006) 0.94
Antigenic domain 1 is required for oligomerization of human cytomegalovirus glycoprotein B. J Virol (2005) 0.94
A cytomegalovirus-based vaccine expressing a single tumor-specific CD8+ T-cell epitope delays tumor growth in a murine model of prostate cancer. J Immunother (2012) 0.92
The novel early region 3 protein E3/49K is specifically expressed by adenoviruses of subgenus D: implications for epidemic keratoconjunctivitis and adenovirus evolution. Virology (2002) 0.92
Nontransformed, GM-CSF-dependent macrophage lines are a unique model to study tissue macrophage functions. Proc Natl Acad Sci U S A (2013) 0.91
M94 is essential for the secondary envelopment of murine cytomegalovirus. J Virol (2011) 0.90
Metabolic labeling of newly transcribed RNA for high resolution gene expression profiling of RNA synthesis, processing and decay in cell culture. J Vis Exp (2013) 0.89
Cytomegalovirus downregulates IRE1 to repress the unfolded protein response. PLoS Pathog (2013) 0.88
The role of cell types in cytomegalovirus infection in vivo. Eur J Cell Biol (2011) 0.86
Engineering of cytomegalovirus genomes for recombinant live herpesvirus vaccines. Int J Med Microbiol (2007) 0.86
A functional genomics approach to Kaposi's sarcoma. Ann N Y Acad Sci (2002) 0.85
A beta-herpesvirus with fluorescent capsids to study transport in living cells. PLoS One (2012) 0.84
Block of death-receptor apoptosis protects mouse cytomegalovirus from macrophages and is a determinant of virulence in immunodeficient hosts. PLoS Pathog (2012) 0.84
Cytomegalovirus replicon-based regulation of gene expression in vitro and in vivo. PLoS Pathog (2012) 0.84
Characterization of conserved region 2-deficient mutants of the cytomegalovirus egress protein pM53. J Virol (2012) 0.84
Absence of frequent herpesvirus transmission in a nonhuman primate predator-prey system in the wild. J Virol (2013) 0.83
Mouse cytomegalovirus egress protein pM50 interacts with cellular endophilin-A2. Cell Microbiol (2012) 0.82
A single-dose cytomegalovirus-based vaccine encoding tetanus toxin fragment C induces sustained levels of protective tetanus toxin antibodies in mice. Vaccine (2012) 0.82
Natural killer cells are required for extramedullary hematopoiesis following murine cytomegalovirus infection. Cell Host Microbe (2013) 0.82
Subcellular trafficking and functional importance of herpes simplex virus type 1 glycoprotein M domains. J Gen Virol (2015) 0.79
Cytomegalovirus immune evasion of myeloid lineage cells. Med Microbiol Immunol (2015) 0.78
A novel Cre recombinase imaging system for tracking lymphotropic virus infection in vivo. PLoS One (2009) 0.77
Dominant-negative proteins in herpesviruses - from assigning gene function to intracellular immunization. Viruses (2009) 0.77
A cell free protein fragment complementation assay for monitoring the core interaction of the human cytomegalovirus nuclear egress complex. Antiviral Res (2012) 0.77
Systemic and local infection routes govern different cellular dissemination pathways during gammaherpesvirus infection in vivo. J Virol (2013) 0.75